Advert - Allergan

• Date posted
  25 September 2020
• Sanction
  Advertisement,
• Case number/s
  AUTH/3291/12/19 - Aesthetics Health Professional v Allergan

For promoting Botox (botulinum toxin type A) to the public via
corporate and personal Instagram accounts, Allergan was ruled
in breach of the following clauses of the Code:

Clause 2 - Bringing discredit upon, and reducing confidence
in, the pharmaceutical industry

Clause 9.1 - Failing to maintain high standards

Clause 26.1 - Promoting a prescription only medicine to the
public